Allergan

European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions

11 Mar 2016

The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland

Allergen deal to help Pfizer save $35 bn in annual taxes: report

26 Feb 2016

The Pfizer-Allergen deal is the largest inversion ever, which would potentially lower the merged entity's annual tax bill by $35 billion in the United States

Pfizer to take over Allergan in historic $150-bn deal

23 Nov 2015

The deal, the largest ever in the healthcare sector, will make Pfizer the world’s biggest drug maker, but the tax-cutting ‘inversion’ move is sure to draw political ire

Pfizer said to be in $150-bn merger talks with Allergan

19 Nov 2015

Merger talks are being held between US pharmaceutical giant Pfizer and Irish drug maker Allergan Plc, to create a global pharmaceutical behemoth worth over $300 billion

Pfizer, Allergan mull largest pharma merger

29 Oct 2015

US drug giant Pfizer Inc and Irish pharmaceutical company Allergan Plc are weighing a merger plan, which would create the world’s largest drug company with a market cap of more than $300 billion

Teva in talks to buy Allergan's generic-drug unit for $45 bn: report

27 Jul 2015

A deal with Allergan would indicate that Teva could be considering abandoning its plan to buy Mylan NV after the Netherlands-based company rejected its $40-billion takeover offer

Botox-maker Allergan Plc to buy Kythera Biopharmaceuticals for $2.1 bn

18 Jun 2015

Botox-maker Allergan Plc yesterday struck a deal to buy Kythera Biopharmaceuticals Inc in a $2.1-billion cash-and-stock deal, in a bid to expand its portfolio of cosmetic treatments